Esperion Therapeutics Inc (ESPR) Price
ESPR Stock Price Chart
ESPR Financial
Esperion Therapeutics Inc
$3.1
7.63%
$0.22
$3.1
0%
$0
Income
Balance sheet
Cash flow
Annual
Quarterly
ESPR Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|
| Revenue | 303 | 332 | 116 | 75 | 78 | 227 |
| Revenue Growth (YoY) | 3% | 186% | 55% | -4% | -66% | 53% |
| Cost of Revenue | 127 | 68 | 43 | 27 | 14 | 2 |
| Gross Profit | 176 | 263 | 73 | 48 | 64 | 225 |
| Selling, General & Admin | 161 | 163 | 142 | 109 | 171 | 199 |
| Research & Development | 44 | 46 | 86 | 118 | 106 | 146 |
| Operating Expenses | 206 | 209 | 228 | 228 | 277 | 346 |
| Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0 | 3 | 0 |
| Pretax Income | -105 | -51 | -209 | -233 | -269 | -143 |
| Income Tax Expense | 0 | -- | -- | -- | -- | -- |
| Net Income | -105 | -51 | -209 | -233 | -269 | -143 |
| Net Income Growth | 22% | -76% | -10% | -13% | 88% | 47% |
| Shares Outstanding (Diluted) | 200.73 | 187.18 | 103.1 | 66.4 | 28.9 | 27.5 |
| Shares Change (YoY) | 3% | 82% | 55% | 130% | 5% | 1% |
| EPS (Diluted) | -0.53 | -0.27 | -2.02 | -3.52 | -9.31 | -5.23 |
| EPS Growth | 22% | -86% | -42% | -62% | 78% | 46% |
| Free Cash Flow | -93 | -23 | -135 | -174 | -263 | -98 |
| Free Cash Flow Per Share | -0.46 | -0.12 | -1.3 | -2.62 | -9.1 | -3.56 |
| Gross Margin | 58.08% | 79.21% | 62.93% | 64% | 82.05% | 99.11% |
| Operating Margin | -9.57% | 16.26% | -133.62% | -238.66% | -273.07% | -53.3% |
| Profit Margin | -34.65% | -15.36% | -180.17% | -310.66% | -344.87% | -62.99% |
| Free Cash Flow Margin | -30.69% | -6.92% | -116.37% | -231.99% | -337.17% | -43.17% |
| EBITDA | -29 | 54 | -155 | -179 | -213 | -121 |
| EBITDA Margin | -9.57% | 16.26% | -133.62% | -238.66% | -273.07% | -53.3% |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -29 | 54 | -155 | -179 | -213 | -121 |
| EBIT Margin | -9.57% | 16.26% | -133.62% | -238.66% | -273.07% | -53.3% |
| Effective Tax Rate | 0% | -- | -- | -- | -- | -- |
Follow-Up Questions
Esperion Therapeutics Inc 的關鍵財務報表是什麼？
ESPR 的關鍵財務比率是什麼？
Esperion Therapeutics Inc 的收入按細分市場或地理位置如何劃分？
Esperion Therapeutics Inc 是否盈利？
Esperion Therapeutics Inc 有負債嗎？
Esperion Therapeutics Inc 的流通股有多少？
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About ESPR